Found: 20
Select item for more details and to access through your institution.
Teenagers and Adolescents with Hemophilia–Need for a Specific Approach.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 17, p. 5121, doi. 10.3390/jcm13175121
- By:
- Publication type:
- Article
Bleeding control improves after switching to emicizumab: Real‐world experience of 177 children in the PedNet registry.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 685, doi. 10.1111/hae.15015
- By:
- Publication type:
- Article
Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 306, doi. 10.1111/hae.14934
- By:
- Publication type:
- Article
Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres.
- Published in:
- Haemophilia, 2023, v. 29, n. 5, p. 1291, doi. 10.1111/hae.14847
- By:
- Publication type:
- Article
Long‐term joint outcomes in adolescents with moderate or severe haemophilia A.
- Published in:
- Haemophilia, 2022, v. 28, n. 6, p. 1054, doi. 10.1111/hae.14636
- By:
- Publication type:
- Article
Emicizumab in previously untreated and minimally treated infants.
- Published in:
- Haemophilia, 2022, v. 28, n. 2, p. e61, doi. 10.1111/hae.14485
- By:
- Publication type:
- Article
Patients on emicizumab prophylaxis with previously tolerized inhibitors: Is there a risk of inhibitors recurrence?
- Published in:
- Haemophilia, 2022, v. 28, n. 2, p. e36, doi. 10.1111/hae.14466
- By:
- Publication type:
- Article
Real‐world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e698, doi. 10.1111/hae.14432
- By:
- Publication type:
- Article
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 932, doi. 10.1111/hae.14381
- By:
- Publication type:
- Article
Management and outcomes of paediatric patients on emicizumab prophylaxis undergoing surgical procedures: Experience from a large haemophilia centre in the UK.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e620, doi. 10.1111/hae.14358
- By:
- Publication type:
- Article
Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. 478, doi. 10.1111/hae.13997
- By:
- Publication type:
- Article
Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers.
- Published in:
- Journal of Blood Medicine, 2021, v. 12, p. 209, doi. 10.2147/JBM.S304597
- By:
- Publication type:
- Article
IFNɣ Block, Treosulfan Conditioning and αβ T Cell Deplete PBSCT for XIAP-Deficient HLH.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 4, p. 482, doi. 10.1111/j.1365-2141.2011.08752.x
- By:
- Publication type:
- Article
Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy – results from a single UK centre.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 5, p. 844, doi. 10.1111/bjh.17093
- By:
- Publication type:
- Article
Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 5, p. 696, doi. 10.1111/bjh.14689
- By:
- Publication type:
- Article
Single centre experience of the use of emicizumab in previously untreated and minimally treated patients under 18 months of age.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 6, p. 1, doi. 10.1002/pbc.30941
- By:
- Publication type:
- Article
SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 9, p. 3600, doi. 10.1172/JCI80347
- By:
- Publication type:
- Article
Congenital Thrombotic Thrombocytopenic Purpura Associated With Moyamoya Syndrome in a 3-Year-Old Girl: A Case Report.
- Published in:
- 2012
- By:
- Publication type:
- Case Study